Evrofarma SA (EVROF) — Working Capital to Net Assets Ratio

Evrofarma SA (EVROF) has a Working Capital to Net Assets ratio of 43.1% as of December 2022. Working capital of €6.04 Million (current assets of €18.71 Million minus current liabilities of €12.67 Million) is measured against net assets of €14.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Evrofarma SA (EVROF) net asset quality to measure how much of total assets are equity-financed.